硬化症-话题@MedSci

#硬化症#

413篇内容 | 2689人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1983031, encodeId=924619830312d, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=J Rheumatol：系统性硬化症中手指溃疡临床评估评分的初步验证, objectType=article, longId=154167, objectId=710f15416e21, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=710f15416e21, replyNumber=0, likeNumber=73, createdTime=2019-09-18, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=710f15416e21, moduleTitle=J Rheumatol：系统性硬化症中手指溃疡临床评估评分的初步验证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=710f15416e21)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983013, encodeId=6d0719830134d, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=新生儿结节性硬化症1例, objectType=article, longId=141086, objectId=3af3141086f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3af3141086f6, replyNumber=0, likeNumber=83, createdTime=2019-02-15, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3af3141086f6, moduleTitle=新生儿结节性硬化症1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3af3141086f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983037, encodeId=8af7198303eb7, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=PLos One：TNFSF13B功能性变异体不参与系统性硬化症和巨细胞动脉炎易感性, objectType=article, longId=156816, objectId=2e5115681600, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e5115681600, replyNumber=0, likeNumber=62, createdTime=2019-06-13, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e5115681600, moduleTitle=PLos One：TNFSF13B功能性变异体不参与系统性硬化症和巨细胞动脉炎易感性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e5115681600)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983023, encodeId=d30619830233b, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=NEJM：芬戈莫德与干扰素β-1a对儿童多发性硬化症的疗效比较, objectType=article, longId=148777, objectId=3e5c148e7712, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e5c148e7712, replyNumber=0, likeNumber=122, createdTime=2018-10-08, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e5c148e7712, moduleTitle=NEJM：芬戈莫德与干扰素β-1a对儿童多发性硬化症的疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e5c148e7712)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983033, encodeId=cf41198303313, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Neurology：多发性硬化症儿童使用新型疾病修饰疗法安全吗？, objectType=article, longId=154630, objectId=6d4915463042, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d4915463042, replyNumber=0, likeNumber=88, createdTime=2019-07-24, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d4915463042, moduleTitle=Neurology：多发性硬化症儿童使用新型疾病修饰疗法安全吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d4915463042)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983034, encodeId=4da91983034fa, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Arthritis Rheumatol：系统性硬化症中尺动脉闭塞与血管病变严重程度标志物, objectType=article, longId=155921, objectId=a0fc15592199, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0fc15592199, replyNumber=0, likeNumber=58, createdTime=2019-02-18, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0fc15592199, moduleTitle=Arthritis Rheumatol：系统性硬化症中尺动脉闭塞与血管病变严重程度标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0fc15592199)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983020, encodeId=cce019830206f, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=FDA接受Merck制药关于克拉屈滨治疗多发性硬化症的申请, objectType=article, longId=145542, objectId=252f1455429f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=252f1455429f, replyNumber=0, likeNumber=89, createdTime=2018-10-14, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=252f1455429f, moduleTitle=FDA接受Merck制药关于克拉屈滨治疗多发性硬化症的申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=252f1455429f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983021, encodeId=327019830213e, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=J Rheumatol：系统性硬化症—系统性红斑狼疮重叠综合征的流行病学和生存率, objectType=article, longId=146423, objectId=5f881464231d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f881464231d, replyNumber=0, likeNumber=81, createdTime=2018-11-09, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f881464231d, moduleTitle=J Rheumatol：系统性硬化症—系统性红斑狼疮重叠综合征的流行病学和生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f881464231d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983024, encodeId=66511983024b6, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=N Engl J Med：异丁司特治疗进行性多发性硬化症喜忧参半, objectType=article, longId=149894, objectId=85cd149894b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85cd149894b4, replyNumber=0, likeNumber=73, createdTime=2018-11-23, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85cd149894b4, moduleTitle=N Engl J Med：异丁司特治疗进行性多发性硬化症喜忧参半, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85cd149894b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982998, encodeId=cbad198299892, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Neurology：多发性硬化症女性妊娠期暴露于那他珠单抗对胎儿有何影响？, objectType=article, longId=132984, objectId=eca9132984dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eca9132984dd, replyNumber=0, likeNumber=59, createdTime=2019-03-03, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eca9132984dd, moduleTitle=Neurology：多发性硬化症女性妊娠期暴露于那他珠单抗对胎儿有何影响？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eca9132984dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982994, encodeId=783e198299437, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Biogen与AbbVie正式宣布：多发性硬化症药物达利珠单抗退市, objectType=article, longId=131542, objectId=9be113154202, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9be113154202, replyNumber=0, likeNumber=64, createdTime=2018-10-12, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9be113154202, moduleTitle=Biogen与AbbVie正式宣布：多发性硬化症药物达利珠单抗退市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9be113154202)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983010, encodeId=fe98198301002, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Lancet Child Adol Health：依维莫司用于难治性癫痫合并结节性硬化症患儿的辅助治疗, objectType=article, longId=139024, objectId=84d813902457, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84d813902457, replyNumber=0, likeNumber=81, createdTime=2019-04-21, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84d813902457, moduleTitle=Lancet Child Adol Health：依维莫司用于难治性癫痫合并结节性硬化症患儿的辅助治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84d813902457)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983036, encodeId=78c8198303644, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Semin Arthritis Rheu：甲襞毛细血管镜检查有助于预测系统性硬化症的未来结局吗？, objectType=article, longId=156568, objectId=0f27156568f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f27156568f4, replyNumber=0, likeNumber=64, createdTime=2019-08-01, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f27156568f4, moduleTitle=Semin Arthritis Rheu：甲襞毛细血管镜检查有助于预测系统性硬化症的未来结局吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f27156568f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982992, encodeId=6b1c198299255, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Neurology：那他珠单抗治疗的多发性硬化症妇女妊娠决策-产妇风险！, objectType=article, longId=129335, objectId=4cc112933518, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4cc112933518, replyNumber=0, likeNumber=69, createdTime=2018-07-16, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4cc112933518, moduleTitle=Neurology：那他珠单抗治疗的多发性硬化症妇女妊娠决策-产妇风险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4cc112933518)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983011, encodeId=722c198301166, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Neurology：复发缓解多发性硬化症患者治疗方案选择——芬戈莫德 vs富马酸二甲酯, objectType=article, longId=140255, objectId=9662140255bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9662140255bb, replyNumber=0, likeNumber=80, createdTime=2019-02-27, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9662140255bb, moduleTitle=Neurology：复发缓解多发性硬化症患者治疗方案选择——芬戈莫德 vs富马酸二甲酯, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9662140255bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982996, encodeId=143119829962f, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Neurology：多发性硬化症发病率和患病率的时间趋势！, objectType=article, longId=132818, objectId=4e57132818c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e57132818c3, replyNumber=0, likeNumber=62, createdTime=2019-01-05, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e57132818c3, moduleTitle=Neurology：多发性硬化症发病率和患病率的时间趋势！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e57132818c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983018, encodeId=fbc219830189b, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Cell Metab：间歇性禁食改善多发性硬化症, objectType=article, longId=144117, objectId=b19714411ee2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b19714411ee2, replyNumber=0, likeNumber=76, createdTime=2019-02-08, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b19714411ee2, moduleTitle=Cell Metab：间歇性禁食改善多发性硬化症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b19714411ee2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982986, encodeId=bdff1982986ca, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=JAMA Neurol：利妥昔单抗、富马酸二甲酯、芬戈莫德、那他珠单抗以及其他症状缓解治疗药物对复发缓解多发性硬化症的治疗效果比较研究, objectType=article, longId=126027, objectId=39af12602e4e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39af12602e4e, replyNumber=0, likeNumber=64, createdTime=2018-10-19, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39af12602e4e, moduleTitle=JAMA Neurol：利妥昔单抗、富马酸二甲酯、芬戈莫德、那他珠单抗以及其他症状缓解治疗药物对复发缓解多发性硬化症的治疗效果比较研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=39af12602e4e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983004, encodeId=cba519830045e, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=结节性硬化症突破性疗法：西罗莫司凝胶, objectType=article, longId=136294, objectId=ec0f13629473, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec0f13629473, replyNumber=0, likeNumber=82, createdTime=2018-11-29, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec0f13629473, moduleTitle=结节性硬化症突破性疗法：西罗莫司凝胶, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec0f13629473)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982978, encodeId=d79019829e89f, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=J Rheumatol ：泊马度胺在系统性硬化症间质性肺病患者中的应用, objectType=article, longId=119293, objectId=951311929378, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=951311929378, replyNumber=0, likeNumber=77, createdTime=2018-08-27, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=951311929378, moduleTitle=J Rheumatol ：泊马度胺在系统性硬化症间质性肺病患者中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=951311929378)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

硬化症

2020-05-29

30397604 (审核中...)

前往app查看评论内容

#硬化症#

J Rheumatol：系统性硬化症中手指溃疡临床评估评分的初步验证

2019-09-18

30397604 (审核中...)

前往app查看评论内容

#硬化症#

新生儿结节性硬化症1例

2019-02-15

30397604 (审核中...)

前往app查看评论内容

#硬化症#

PLos One：TNFSF13B功能性变异体不参与系统性硬化症和巨细胞动脉炎易感性

2019-06-13

30397604 (审核中...)

前往app查看评论内容

#硬化症#

NEJM：芬戈莫德与干扰素β-1a对儿童多发性硬化症的疗效比较

2018-10-08

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Neurology：多发性硬化症儿童使用新型疾病修饰疗法安全吗？

2019-07-24

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Arthritis Rheumatol：系统性硬化症中尺动脉闭塞与血管病变严重程度标志物

2019-02-18

30397604 (审核中...)

前往app查看评论内容

#硬化症#

FDA接受Merck制药关于克拉屈滨治疗多发性硬化症的申请

2018-10-14

30397604 (审核中...)

前往app查看评论内容

#硬化症#

J Rheumatol：系统性硬化症—系统性红斑狼疮重叠综合征的流行病学和生存率

2018-11-09

30397604 (审核中...)

前往app查看评论内容

#硬化症#

N Engl J Med：异丁司特治疗进行性多发性硬化症喜忧参半

2018-11-23

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Neurology：多发性硬化症女性妊娠期暴露于那他珠单抗对胎儿有何影响？

2019-03-03

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Biogen与AbbVie正式宣布：多发性硬化症药物达利珠单抗退市

2018-10-12

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Lancet Child Adol Health：依维莫司用于难治性癫痫合并结节性硬化症患儿的辅助治疗

2019-04-21

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Semin Arthritis Rheu：甲襞毛细血管镜检查有助于预测系统性硬化症的未来结局吗？

2019-08-01

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Neurology：那他珠单抗治疗的多发性硬化症妇女妊娠决策-产妇风险！

2018-07-16

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Neurology：复发缓解多发性硬化症患者治疗方案选择——芬戈莫德 vs富马酸二甲酯

2019-02-27

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Neurology：多发性硬化症发病率和患病率的时间趋势！

2019-01-05

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Cell Metab：间歇性禁食改善多发性硬化症

2019-02-08

30397604 (审核中...)

前往app查看评论内容

#硬化症#

JAMA Neurol：利妥昔单抗、富马酸二甲酯、芬戈莫德、那他珠单抗以及其他症状缓解治疗药物对复发缓解多发性硬化症的治疗效果比较研究

2018-10-19

30397604 (审核中...)

前往app查看评论内容

#硬化症#

结节性硬化症突破性疗法：西罗莫司凝胶

2018-11-29

30397604 (审核中...)

前往app查看评论内容

#硬化症#

J Rheumatol ：泊马度胺在系统性硬化症间质性肺病患者中的应用

2018-08-27

科室
- - 订阅+
  - 更多科室
工具
服务